Menu
Recruiting NCT06872736

Wereables for Upper Limb Functionality in Hemiparesis

Phase II / Phase III Interventional Unilateral Cerebral Palsy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: WeFun-wearable activated, WeFun-wearable desactivated.
Who it may be relevant to
Registry conditions: Unilateral Cerebral Palsy. Basic parameters: 3 years — 8 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Spain
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Innovative Use of Wereable Technology for Improving Functionality in Children with Unilateral Cerebral Palsy

Overview

The project is configured as a national interventional study that aims to determine the effectiveness of an intervention strategy using wearable technology, tailored to improve function (WeFun-wearable), on the spontaneous use of the affected upper extremity, activities of daily living and the participation in children with unilateral cerebral palsy.

Detailed description

Cerebral palsy represents the most common paediatric neurological disorders. Unilateral cerebral palsy (UCP) subtype is the most frequent, accounting for about 0.6-1 per 1000 live births. Many children with UCP experience upper limb dysfunction, which is often more pronounced than that on lower extremity limitation. Rehabilitation strategies on the affected upper limb are of paramount importance to diminish limitations, especially those that seek to improve independence and wellbeing. These strategies are often provided through technology, which got into the clinics spotlight years ago, after extensive innovation-driven and knowledge research.

However, technology development has not reached its tops and technology solutions will drive the optimization of scientific evidence-based rehabilitation strategies. In this project, we use scientific knowledge acquired in our laboratory regarding the validation of new technologies to evaluate and treat movement disorders. Specifically, an unprecedented wearable will be used that could assess movement and complement intervention to influence function to such an extent that it would ultimately improve participation and quality of life for children with UCP.

WeFun proposes a home-based multimodal technology-based training, related to the practice of activities of daily life, to improve the use of the affected upper limb. WeFun wearable allows daily assessment of the amount of movement, in combination with training of upper limb movements and daily routines for children with CP. Our hypothesis is that a wearable technology to improve function, the We-Fun-wearable, could be an effective tool for the assessment and approach of the upper limb in children with CP.

This study has the potential to establish a new evidence-based and cost-effective therapy, accessible to children with cerebral palsy and their families, so that a digital solution can be provided for a vulnerable group: children with disabilities.

Interventions

  • Device WeFun-wearable activated
    1 month daily routine program with weekly visits in natural environments (home, community, etc) together with WeFun-weareable to increase spontaneous use of the upper limb in children with UCP during activities of daily life and leisure. Activities are priorized by Canadian Occupational Performance Measure and Goal Atteinment Scale. Programs are designed together with a transdisciplinary team, acting as consultants. Children in the experimental group will have the wearable's experimental movemen
  • Device WeFun-wearable desactivated
    1 month daily routine program with weekly visits in natural environments (home, community, etc) together with WeFun-weareable to increase spontaneous use of the upper limb in children with UCP during activities of daily life and leisure. Activities are priorized by Canadian Occupational Performance Measure and Goal Atteinment Scale. Programs are designed together with a transdisciplinary team, acting as consultants. Children in the control group will not have experimental functions in their wear

Primary outcome measures

  • Bimanual performance/functional hand use [Time frame: Baseline, immediately after the intervention and after 2 months follow-up]
Secondary outcome measures (12)
  • Sociodemographic variables [Time frame: Baseline, immediately after the intervention and after 2 months follow-up]
  • Upper Extremity Use (UEU) - WeFUN-wearable measure [Time frame: Baseline, during intervention period, immediately after the intervention and after 2 months follow-up]
  • Asymmetry Index (AI) - WeFUN-wearable measure [Time frame: Baseline, immediately after the intervention and after 2 months follow-up]
  • Grip strength [Time frame: Baseline, immediately after the intervention and after 2 months follow-up]
  • Static motor fatigability [Time frame: Baseline, immediately after the intervention and after 2 months follow-up]
  • Dynamic motor fatigability [Time frame: Baseline, immediately after the intervention and after 2 months follow-up]
  • Hand Dexetrity [Time frame: Baseline, immediately after the intervention and after 2 months follow-up]
  • Participation measures [Time frame: Baseline, immediately after the intervention and after 2 months follow-up]
  • Quality of life measures [Time frame: Baseline, immediately after the intervention and after 2 months follow-up]
  • Attention measures [Time frame: Baseline, immediately after the intervention and after 2 months follow-up]
  • Self-perceived occupational performance [Time frame: Baseline, immediately after the intervention and after 2 months follow-up]
  • Goal attainment [Time frame: Baseline, immediately after the intervention and after 2 months follow-up]

Eligibility criteria

Inclusion criteria

  • Confirmed diagnosis of UCP.
  • Children aged between 3 and 8 years old.
  • Children rated on levels I to III on the Manual Ability Classification System (MACS).

Exclusion criteria

  • Botulinum toxin injection or surgical interventions in the upper limb within 6 months prior to study entry.
  • Medical complications non-controlled that would interfere with study participation (e.g., not controlled epilepsy).
  • Predominantly athetoid or dystonia movement patterns.
  • Insufficient cognitive level to follow instructions,
  • Non-corrected marked visual impairments.

Families can be retired from the study after starting if:

  • Families don't assist or don't collaborate in the weekly sessions with the reference person.
  • Wearable activity if presumably lower than expected (few recordings of activity, <20%).
  • Families don't provide feedback about daily sessions through the satisfaction system in the app/registration sheet.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Quadruple blind
Primary purpose
Treatment

Study locations

Spain · 1 center
  • Universidade da Coruña — A Coruña

Publications

  • Albrecht EC, Khetani MA. Environmental impact on young children's participation in home-based activities. Dev Med Child Neurol. 2017 Apr;59(4):388-394. doi: 10.1111/dmcn.13360. Epub 2016 Dec 17. PMID 27988938
  • Reid LB, Rose SE, Boyd RN. Rehabilitation and neuroplasticity in children with unilateral cerebral palsy. Nat Rev Neurol. 2015 Jul;11(7):390-400. doi: 10.1038/nrneurol.2015.97. Epub 2015 Jun 16. PMID 26077839
  • Gordon AM, Bleyenheuft Y, Steenbergen B. Pathophysiology of impaired hand function in children with unilateral cerebral palsy. Dev Med Child Neurol. 2013 Nov;55 Suppl 4:32-7. doi: 10.1111/dmcn.12304. PMID 24237277
  • Carton de Tournai A, Herman E, Ebner-Karestinos D, Gathy E, Araneda R, Renders A, De Clerck C, Kilcioglu S, Dricot L, Macq B, Vandermeeren Y, Bleyenheuft Y. Hand-Arm Bimanual Intensive Therapy Including Lower Extremities in Infants With Unilateral Cerebral Palsy: A Randomized Clinical Trial. JAMA Netw Open. 2024 Nov 4;7(11):e2445133. doi: 10.1001/jamanetworkopen.2024.45133. PMID 39556397

Identifiers

NCT: NCT06872736 · PID2021-126782OA-I00 · PID2021-126782OA-I00

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗